Trump Administration Rolls Out New Drug-Pricing Deals with 9 More Companies
Trump Administration Rolls Out New Drug-Pricing Deals with 9 More Companies
The Trump administration has announced deals with nine more drugmakers aimed at lowering pharmaceutical prices, bringing its total number of drug-pricing agreements to 14.
According to a report by CNBC [1], the deals were announced on Friday, December 19, 2025. The administration has been pushing to lower drug prices for Americans, which are on average nearly three times higher than overseas.
The new deals include agreements with pharmaceutical companies such as [list of companies]. These companies have agreed to lower their prices on certain medications, making them more affordable for patients.
The Trump administration has been working to lower drug prices for several years, and these new deals are a significant step in that effort. The administration has also been working to increase transparency in the pharmaceutical industry, making it easier for patients to compare prices and make informed decisions about their care.
The new deals are part of the administration's broader effort to lower healthcare costs and improve access to affordable care. The administration has also taken steps to increase competition in the pharmaceutical industry, which it believes will help drive down prices.
The impact of the new deals on patients and the pharmaceutical industry is still unclear. However, the administration believes that the deals will help make medications more affordable for patients and increase competition in the industry.
Pharma Stocks Advance
The announcement of the new deals has sent pharma stocks advancing, with many companies seeing significant gains. According to a report by MarketWatch [5], the stocks of several pharmaceutical companies have risen significantly since the announcement.
The Trump administration's efforts to lower drug prices have been met with both praise and criticism. Some have praised the administration's efforts to increase transparency and competition in the pharmaceutical industry, while others have criticized the administration's approach as too aggressive.
The impact of the Trump administration's efforts to lower drug prices will likely be felt for years to come. The administration's efforts have the potential to make medications more affordable for patients and increase competition in the pharmaceutical industry.
Sources
[1] Nine of the largest pharma companies ink deals with Trump to lower drug prices
[2] Pharma stocks advance as Trump rolls out drug-pricing deals with 9 more companies
[3] Trump administration imposes restrictions on Mexican train crews operating inside US